28.40
-0.60
(-2.07%)
At close: January 10 at 11:40:25 AM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in INR | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 8 | 3 | 33 | 32 |
| Avg. Estimate | 274.96B | 283.27B | 1.1T | 1.26T |
| Low Estimate | 271.47B | 279.53B | 1.07T | 1.18T |
| High Estimate | 279.26B | 289.17B | 1.14T | 1.33T |
| Year Ago Sales | 247.76B | 247.42B | 1.62T | 1.1T |
| Sales Growth (year/est) | 10.98% | 14.49% | -31.87% | 13.76% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ICBA.F | -- | -- | -- | -- |
| S&P 500 | 8.59% | 11.42% | 13.98% | 13.43% |
Upgrades & Downgrades
| Upgrade | B of A Securities: Neutral to Buy | 7/27/2020 |
| Upgrade | Goldman Sachs: Neutral to Buy | 10/24/2016 |
| Upgrade | UBS: Hold to Buy | 10/21/2016 |
| Downgrade | Goldman Sachs: Buy to Neutral | 5/3/2016 |
| Upgrade | Credit Suisse: Neutral to Outperform | 4/21/2016 |
| Upgrade | Goldman Sachs: Neutral to Buy | 9/14/2015 |